13D/13G Filings - GenScript Biotech Corp

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
8:34 pm
Unchanged
2023-12-31 13G Legend Biotech Corporation
LEGN
GenScript Biotech Corp 174,497,556
47.990%
0
(Unchanged)
Filing
History
2023-02-14
4:02 pm
Unchanged
2022-12-31 13G Legend Biotech Corporation
LEGN
GenScript Biotech Corp 174,497,556
52.120%
0
(Unchanged)
Filing
History
2022-03-11
5:02 pm
Purchase
2021-12-31 13G Legend Biotech Corporation
LEGN
GenScript Biotech Corp 174,497,556
57.100%
4,500,000increase
(+2.65%)
Filing
History
2021-02-16
07:27 am
Purchase
2020-12-31 13G Legend Biotech Corporation
LEGN
GenScript Biotech Corp 169,997,556
64.300%
169,997,556increase
(New Position)
Filing
History